"Psychopharmacology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The study of the effects of drugs on mental and behavioral activity.
| Descriptor ID |
D011600
|
| MeSH Number(s) |
F04.096.712 F04.570.505 H01.158.703.546 H02.628.546
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Psychopharmacology".
Below are MeSH descriptors whose meaning is more specific than "Psychopharmacology".
This graph shows the total number of publications written about "Psychopharmacology" by people in this website by year, and whether "Psychopharmacology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Psychopharmacology" by people in Profiles.
-
How a Psychopharmacology Clinical Trial Site in the Seattle Area Managed Clinical Trials and Patient Care During the COVID-19 Pandemic. Am J Geriatr Psychiatry. 2020 09; 28(9):999-1003.
-
[Attention to psychiatry and pharmacotherapy during the COVID-19 pandemic]. Tijdschr Psychiatr. 2020; 62(6):427-432.
-
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP). Eur Neuropsychopharmacol. 2019 12; 29(12):1301-1311.
-
Psychopharmacology and ethnicity: A comparative study on Senegalese and Italian men. World J Biol Psychiatry. 2020 04; 21(4):300-307.
-
Placebo and cultural responses. Nord J Psychiatry. 2018 Sep; 72(sup1):S33-S35.
-
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions. Int Rev Psychiatry. 2017 10; 29(5):425-435.
-
Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des. 2009; 15(22):2603-14.